scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Marksans Pharma Ltd

Feedback
Marksans Pharma Ltd

Marksans Pharma Ltd (MARKSANS) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 2,572
Mar 10, 2025 09:04 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹207.17
₹0.00 (-2.16%)
₹0 Low
Today’s Performance
₹0 High
₹130 Low
52 Week’s Performance
₹358.7 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -2.16%
  • 1 Week 1.21%
  • 1 Month -24.09%
  • 3 Months -37.57%
  • 6 Months -19.82%
  • 1 Year 38.53%
  • 3 Years 65.26%
  • 5 Years 70.10%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 1.15
  • 52-Week Low (₹) 130.00
  • 52-Week High (₹) 358.70
  • Price-to-Book (X)* 4.12
  • Dividend Yield (%) 0.29
  • Price-to-Earnings (P/E) (X)* 25.49
  • Earnings Per Share (₹) 8.13
  • Sector Price Earning (X)* 32.69
  • Market Cap (₹ Cr.)* 9,388.19
  • * Vaues as of last close price

COMPETITORS

BT TV

BT TV Excl, MCA Secretary On PM Internship Scheme’s Impact 19:41 BT TV Excl, MCA Secretary On PM Internship Scheme’s Impact
Designer Rahul Mishra Decodes The Importance Of Handmade, Heritage-Driven Fashion In AI Era 1:48 Designer Rahul Mishra Decodes The Importance Of Handmade, Heritage-Driven Fashion In AI Era
India Today Conclave: Despite IT Talent, Why Has India Not Created Its Own DeepSeek? 2:36 India Today Conclave: Despite IT Talent, Why Has India Not Created Its Own DeepSeek?
India's Sovereign AI: Why India Must Manufacture Intelligence, Not Just Rely on Global Models! 2:47 India's Sovereign AI: Why India Must Manufacture Intelligence, Not Just Rely On Global Models!
Telangana CM Revanth Reddy: Need A National Consensus To Lower The Fiscal Burden Of Political Sops 4:47 Telangana CM Revanth Reddy: Need A National Consensus To Lower The Fiscal Burden Of Political Sops
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE

No Data For Block Deal.

*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Jun 15, 2021 Sell
CRONY VYAPAR PVT LTD
  • Qty 2800172
  • Average Price ₹93.69
Jun 15, 2021 PURCHASE
CRONY VYAPAR PVT LTD
  • Qty 2900172
  • Average Price ₹93.75
Jun 15, 2021 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 3004279
  • Average Price ₹93.09
Jun 15, 2021 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 3004279
  • Average Price ₹93.18
Jun 14, 2021 Sell
PARTH INFIN BROKERS PVT LTD
  • Qty 3026733
  • Average Price ₹94.88
Jun 14, 2021 Sell
XTX MARKETS LLP
  • Qty 2814707
  • Average Price ₹92.42
Jun 14, 2021 PURCHASE
PARTH INFIN BROKERS PVT LTD
  • Qty 3011733
  • Average Price ₹94.60
Jun 14, 2021 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 4772250
  • Average Price ₹92.29
Jun 14, 2021 PURCHASE
VAIBHAV STOCK AND DERIVATIVES BROKING PRIVATE LIMITED
  • Qty 2755545
  • Average Price ₹90.87
Jun 14, 2021 PURCHASE
XTX MARKETS LLP
  • Qty 2814707
  • Average Price ₹92.19
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Marksans Pharma Ltd share price previously?
Marksans Pharma Ltd share price was down by -2.16% from the previous closing price of ₹211.75.
Who are peers of Marksans Pharma Ltd?
The peers of Marksans Pharma Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Aurobindo Pharma Ltd, Alkem Laboratories Ltd,
Who is/are the promoter/promoters of Marksans Pharma Ltd?
The promotor/promotors of Marksans Pharma Ltd are Mark Saldanha, Harshavardhan Panigrahi, Seetharama Raju Buddharaju, Sandra Saldanha, Digant Mahesh Parikh, Varddhman Vikramaditya Jain, Abhinna Sundar Mohanty, Sunny Sharma, Shailaja Vardhan.
What has been 52-week high of Marksans Pharma Ltd stocks?
The highest price of Marksans Pharma Ltd stock is ₹358.70 in the last 52-week.
What is the share price of Marksans Pharma Ltd (MARKSANS) today on NSE?
As on Mar 10, 2025, Marksans Pharma Ltd (MARKSANS)’s share price on NSE is Rs 207.17
What is the market cap of Marksans Pharma Ltd (MARKSANS?)
The current market capitalisation of Marksans Pharma Ltd (MARKSANS) is 9,388.19 crores
What is Marksans Pharma Ltd Share symbol?
The symbol of Marksans Pharma Ltd is MARKSANS.
What is the PE ratio of Marksans Pharma Ltd (MARKSANS)?
The current PE ratio of Marksans Pharma Ltd (MARKSANS) is 25.49.
What is the PB ratio of Marksans Pharma Ltd (MARKSANS)?
The current PB ratio of Marksans Pharma Ltd (MARKSANS) is 4.12.
Today’s High & Low share prices of Marksans Pharma Ltd (MARKSANS) on NSE?
Today, the share price of Marksans Pharma Ltd (MARKSANS) on NSE touched a high of Rs 0 and a low of Rs 0
What price did Marksans Pharma Ltd (MARKSANS) shares open on the NSE today?
On NSE, the share price of Marksans Pharma Ltd (MARKSANS) opened at Rs 211.76
What is the 52-week high of Marksans Pharma Ltd (MARKSANS)?
The 52-week high price of Marksans Pharma Ltd (MARKSANS) is Rs 358.7
What is the 52-week low of Marksans Pharma Ltd (MARKSANS) ?
The 52-week low price of Marksans Pharma Ltd (MARKSANS) is Rs 130

ABOUT MARKSANS PHARMA

Marksans Pharma Ltd, incorporated in the year 1992, has its registered office in 11th Flr GRANDEUR Oshiwara, Veera Desai Extn Rd Andheri(W), Mumbai, Maharashtra, 400053, 91-22-40012000, 91-22-40012011. The main industry in which Marksans Pharma Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Marksans Pharma Ltd is/are MSKA & Associates. In the main management, Mark Saldanha is chairman and Harshavardhan Panigrahi is the company secretary for Marksans Pharma Ltd.

  • MS Mark Saldanha Chairman & Managing Director
  • HP Harshavardhan Panigrahi Company Sec. & Compli. Officer
  • SRB Seetharama Raju Buddharaju Non-Exec. & Independent Dir.
  • SS Sandra Saldanha Whole-time Director
  • DMP Digant Mahesh Parikh Non-Exec. & Independent Dir.
  • VVJ Varddhman Vikramaditya Jain Whole-time Director
  • ASM Abhinna Sundar Mohanty Non-Exec. & Independent Dir.
  • SS Sunny Sharma Non Executive Director
  • SV Shailaja Vardhan Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement